These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31355187)

  • 1. Docking, Interaction Fingerprint, and Three-Dimensional Quantitative Structure-Activity Relationship (3D-QSAR) of Sigma1 Receptor Ligands, Analogs of the Neuroprotective Agent RC-33.
    Velázquez-Libera JL; Rossino G; Navarro-Retamal C; Collina S; Caballero J
    Front Chem; 2019; 7():496. PubMed ID: 31355187
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Insights into the Opening of the Occluded Ligand-Binding Pocket of Sigma1 Receptor: Binding of a Novel Bivalent RC-33 Derivative.
    Rossino G; Orellana I; Caballero J; Schepmann D; Wünsch B; Rui M; Rossi D; González-Avendaño M; Collina S; Vergara-Jaque A
    J Chem Inf Model; 2020 Feb; 60(2):756-765. PubMed ID: 31809025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive 3D-QSAR Model Predicts Binding Affinity of Structurally Diverse Sigma 1 Receptor Ligands.
    Peng Y; Dong H; Welsh WJ
    J Chem Inf Model; 2019 Jan; 59(1):486-497. PubMed ID: 30497261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational Study and Modified Design of Selective Dopamine D3 Receptor Agonists.
    Duan X; Zhang X; Xu B; Wang F; Lei M
    Chem Biol Drug Des; 2016 Jul; 88(1):142-54. PubMed ID: 26851125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toward the identification of neuroprotective agents: g-scale synthesis, pharmacokinetic evaluation and CNS distribution of (R)-RC-33, a promising SIGMA1 receptor agonist.
    Marra A; Rossi D; Pignataro L; Bigogno C; Canta A; Oggioni N; Malacrida A; Corbo M; Cavaletti G; Peviani M; Curti D; Dondio G; Collina S
    Future Med Chem; 2016; 8(3):287-95. PubMed ID: 26898712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of 3D-QSAR Model for Acetylcholinesterase Inhibitors Using a Combination of Fingerprint, Molecular Docking, and Structure-Based Pharmacophore Approaches.
    Lee S; Barron MG
    Toxicol Sci; 2015 Nov; 148(1):60-70. PubMed ID: 26202430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational Modeling to Explain Why 5,5-Diarylpentadienamides are TRPV1 Antagonists.
    Caballero J
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33801115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-Based Modeling of Sigma 1 Receptor Interactions with Ligands and Cholesterol and Implications for Its Biological Function.
    Kim M; Bezprozvanny I
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Novel σ
    Morató X; Fernández-Dueñas V; Pérez-Villamor P; Valle-León M; Vela JM; Merlos M; Burgueño J; Ciruela F
    ACS Chem Neurosci; 2023 Jun; 14(11):2201-2207. PubMed ID: 37191585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico drug design of inhibitor of nuclear factor kappa B kinase subunit beta inhibitors from 2-acylamino-3-aminothienopyridines based on quantitative structure-activity relationships and molecular docking.
    Wang JL; Li L; Hu MB; Wu B; Fan WX; Peng W; Wei DN; Wu CJ
    Comput Biol Chem; 2019 Feb; 78():297-305. PubMed ID: 30605855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of RC-33 as a potent and selective σ1 receptor agonist potentiating NGF-induced neurite outgrowth in PC12 cells. Part 2: g-scale synthesis, physicochemical characterization and in vitro metabolic stability.
    Rossi D; Marra A; Picconi P; Serra M; Catenacci L; Sorrenti M; Laurini E; Fermeglia M; Pricl S; Brambilla S; Almirante N; Peviani M; Curti D; Collina S
    Bioorg Med Chem; 2013 May; 21(9):2577-86. PubMed ID: 23498917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.
    Du QS; Gao J; Wei YT; Du LQ; Wang SQ; Huang RB
    J Chem Inf Model; 2012 Apr; 52(4):996-1004. PubMed ID: 22480344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational Analysis of Sigma-1 Receptor's Role in Synaptic Stability.
    Ryskamp DA; Zhemkov V; Bezprozvanny I
    Front Neurosci; 2019; 13():1012. PubMed ID: 31607852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacophore modeling, 3D-QSAR and molecular docking studies of benzimidazole derivatives as potential FXR agonists.
    Sindhu T; Srinivasan P
    J Recept Signal Transduct Res; 2014 Aug; 34(4):241-53. PubMed ID: 25072161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Setup and Validation of a Reliable Docking Protocol for the Development of Neuroprotective Agents by Targeting the Sigma-1 Receptor (S1R).
    Rossino G; Rui M; Pozzetti L; Schepmann D; Wünsch B; Zampieri D; Pellavio G; Laforenza U; Rinaldi S; Colombo G; Morelli L; Linciano P; Rossi D; Collina S
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Imidazoline-1 receptor ligands as apoptotic agents: pharmacophore modeling and virtual docking study.
    Nikolic K; Veljkovic N; Gemovic B; Srdic-Rajic T; Agbaba D
    Comb Chem High Throughput Screen; 2013 May; 16(4):298-319. PubMed ID: 23360165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receptor-based 3D-QSAR studies of checkpoint Wee1 kinase inhibitors.
    Wichapong K; Lindner M; Pianwanit S; Kokpol S; Sippl W
    Eur J Med Chem; 2009 Apr; 44(4):1383-95. PubMed ID: 18976834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain-derived neurotrophic factor for high-throughput evaluation of selective Sigma-1 receptor ligands.
    Dalwadi DA; Kim S; Schetz J; Schreihofer DA; Kim S
    J Pharmacol Toxicol Methods; 2022; 113():107129. PubMed ID: 34678430
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural Requirements of
    Velázquez-Libera JL; Murillo-López JA; F de la Torre A; Caballero J
    Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor-based 3D QSAR analysis of estrogen receptor ligands--merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods.
    Sippl W
    J Comput Aided Mol Des; 2000 Aug; 14(6):559-72. PubMed ID: 10921772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.